How is Parkinson’s diagnosed? Tracked? Importantly, predicted? In the second episode of our “Parkinson’s Science POV” podcast series, MJFF Chief Scientific Officers discuss progress toward better tests for Parkinson’s disease, including a recent report of a brain scan of a key Parkinson’s protein. They discuss imaging, fluid measures and wearable devices and how these objective tools could speed new treatments and improve care.
Listen on the go, by subscribing to our Michael J. Fox Foundation Parkinson's Podcast on iTunes or through any podcast app on your smartphone or tablet. And if you enjoyed what you heard, share it with a friend or leave a review on iTunes. It helps listeners like you find and support our mission.
In this episode, MJFF Vice President of Research Communications, Maggie Kuhl, talks to:
- Brian Fiske, PhD; MJFF Co-Chief Scientific Officer
- Mark Frasier, PhD; MJFF Co-Chief Scientific Officer
View a transcript of this podcast.
Read more about the latest in research and our strategy to move forward faster in our Year in Review publication.
Much of this work and findings stem from our landmark Parkinson’s Progression Markers Initiative (PPMI) study. Join today to contribute to new discoveries and better measures of disease. PPMI especially needs people recently diagnosed with Parkinson’s or with certain risk factors such as a relative with the disease, smell loss or acting out dreams. Anyone over the age of 18 in the United States can join through its online platform. Outside the U.S.? View a list of international recruiting sites.